Arturo G. Porras

Statistics

Publications

Citations

3.4K

H-Index

Active since

1981

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Clinical Research Associates

KU Leuven

Pharmaceutical Product Development (United States)

Arturo G. Porras is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, pharmacokinetics, and clinical pharmacology.

Publications per year

1981–2011

Publications

Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects

Cynthia Guzzo, Christine Furtek, Arturo G. Porras et al. · The Journal of Clinical Pharmacology · 2002 · 366 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

Elliot Ehrich, A. Dallob, I Delepeleire et al. · Clinical Pharmacology & Therapeutics · 1999 · 326 citations

Medicine, Pharmacology, Pharmacotherapy +16

Substrate analog binding to the coupled binuclear copper active site in tyrosinase

Dean E. Wilcox, Arturo G. Porras, Yeong Tsyr Hwang et al. · Journal of the American Chemical Society · 1985 · 311 citations

Natural Sciences, Chemistry, Bioisosterism +13

Safety, Tolerability, and Pharmacokinetics of Escalating High Doses of Ivermectin in Healthy Adult Subjects

Cynthia Guzzo, Christine Furtek, Arturo G. Porras et al. · The Journal of Clinical Pharmacology · 2002 · 311 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Elimination and Biochemical Responses to Intravenous Alendronate in Postmenopausal Osteoporosis

Sohail A. Khan, John А. Kanis, Samuel D Vasikaran et al. · Journal of Bone and Mineral Research · 1997 · 293 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +17

1–5 of 32